Abbott Laboratories (ABT)

Stock Price: $107.79 USD -1.69 (-1.54%)
Updated Oct 23, 2020 4:02 PM EDT - Market closed
After-hours: $108.50 +0.71 (0.66%) Oct 23, 7:56 PM
Zacks Investment Research - 1 day ago

Abbott (ABT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Insider Monkey - 1 day ago

Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen Global Growth Composite Portfolio ret...

The Motley Fool - 1 day ago

You can probably hold onto these winners beyond 2030.

Other stocks mentioned: AZN
Benzinga - 2 days ago

Abbott Laboratories (NYSE: ABT) reported strong third-quarter results Wednesday and looks able to generate double-digit earnings growth going ahead, even without considering testing revenue, a...

The Motley Fool - 2 days ago

The COVID-19 pandemic will likely get worse before it gets better. These two stocks could be safe havens for investors.

Other stocks mentioned: TDOC
Seeking Alpha - 2 days ago

Abbott Laboratories (ABT) CEO Robert Ford on Q3 2020 Results - Earnings Call Transcript

Other stocks mentioned: F
The Motley Fool - 3 days ago

Revenue and earnings beats were only part of the story.

Invezz - 3 days ago

Abbott Laboratories (NYSE: ABT) published its earnings report for the fiscal third quarter on Wednesday. The company said that its earnings in Q3 came in stronger than what analysts had expect...

Zacks Investment Research - 3 days ago

In Q3, Abbott (ABT) registers solid worldwide adoption of FreeStyle Libre System.

Zacks Investment Research - 3 days ago

Thermo Fisher (TMO) posted a big beat this morning, while Verizon (VZ) and Abbott (ABT) topped expectations more mildly.

Other stocks mentioned: TMO, TSLA, VZ, VZA
Zacks Investment Research - 3 days ago

Abbott (ABT) delivered earnings and revenue surprises of 8.89% and 4.67%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Investors Business Daily - 3 days ago

Abbott Laboratories posted Q3 earnings and revenue that exceeded Wall Street expectations, as did its earnings guidance for the year. The post Abbott Laboratories Earnings, Outlook Top Expecta...

Market Watch - 3 days ago

Abbott Laboratories posted stronger-than-expected third-quarter earnings Wednesday and offered upbeat guidance for the full year, despite the uncertainty created by the pandemic. The company p...

Benzinga - 3 days ago

Shares of Abbott Laboratories (NYSE:ABT) rose 1% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 16.67% year over year to $0.98, which be...

PRNewsWire - 3 days ago

ABBOTT PARK, Ill., Oct. 21, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2020. Third-quarter worldwide sales of $8.9 billion ...

InvestorPlace - 3 days ago

Logitech, Philip Morris, Verizon, Abbott Labs and iRobot were our top stock trades for Wednesday. That said, here's a look at the charts.

Other stocks mentioned: IRBT, LOGI, PM, VZ, VZA
Zacks Investment Research - 4 days ago

Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PRNewsWire - 5 days ago

ABBOTT PARK, Ill., Oct. 19, 2020 /PRNewswire/ -- Researchers at the University of Illinois, Urbana-Champaign, Abbott (NYSE: ABT), and the U.S. Air Force Research Lab announced today the result...

The Motley Fool - 6 days ago

These stocks are all up more than 20% this year.

Other stocks mentioned: ADBE, TGT
The Motley Fool - 6 days ago

Solid dividends plus strong growth prospects add up to great stocks to buy.

Other stocks mentioned: BEP, BEPC, IIPR
The Motley Fool - 1 week ago

These companies have benefited significantly from the COVID-19 pandemic already, and it looks like they have much more room to grow.

Other stocks mentioned: NVAX, TDOC
Zacks Investment Research - 1 week ago

Abbott (ABT) is expected to register strong sales in the Adult Nutrition category, banking on growing global demand for its nutrition brand Ensure.

Zacks Investment Research - 1 week ago

Investment in low-beats stocks with a favorable Zacks Rank and positive Earnings ESP will be a sound strategy to enhance one's portfolio.

Other stocks mentioned: CVBF, GGG, LSTR, NEE, SLGN, UNF
Zacks Investment Research - 1 week ago

In the latest trading session, Abbott (ABT) closed at $107.75, marking a -0.57% move from the previous day.

Zacks Investment Research - 1 week ago

Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Forbes - 1 week ago

Our indicative theme of Covid-19 Testing Stocks, which includes medical devices and diagnostic companies that are involved in Covid-19 testing - is up by about 69% year-to-date, significantly ...

Other stocks mentioned: DGX, HOLX, LH, QDEL
Zacks Investment Research - 1 week ago

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Market Watch - 1 week ago

Shares of Abbott Laboratories were down 1.6% in trading on Tuesday, the day after the company said it had received emergency authorization from the Food and Drug Administration for a new COVID...

Zacks Investment Research - 1 week ago

Abbott's (ABT) latest antibody test is expected to give a clearer picture of the rate of recovery post coronavirus infection.

Zacks Investment Research - 1 week ago

Does Abbott (ABT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 week ago

Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research - 1 week ago

Is (ABT) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 week ago

Abbott's (ABT) recent data from an interim clinical study on its ID NOW COVID-19 rapid test reflects the test's capacity to deliver effective, consistent and reliable performance.

The Motley Fool - 1 week ago

A market downturn can't stop these two top healthcare stocks.

Other stocks mentioned: GH
The Motley Fool - 1 week ago

These stocks could share big news this month, loosening the grip of the coronavirus on our lives.

Other stocks mentioned: MRNA
The Motley Fool - 1 week ago

These two companies are both banking on the success of their coronavirus products.

Other stocks mentioned: GILD
The Motley Fool - 1 week ago

Their coronavirus programs are only part of the attraction for these stocks.

Other stocks mentioned: PFE, REGN
The Motley Fool - 2 weeks ago

This healthcare company will benefit from coronavirus-related demand now -- and the rest of its solid business will benefit later.

24/7 Wall Street - 2 weeks ago

If you had asked investors in the middle of March this year if they thought the U.S.

Other stocks mentioned: C, CVX, HD, LMT
The Motley Fool - 2 weeks ago

These stocks are well-positioned whether turbulent times come or not.

Other stocks mentioned: AMZN, DG
The Motley Fool - 2 weeks ago

The interim clinical data indicates that ID NOW flags infected patients in nearly every instance.

The Motley Fool - 2 weeks ago

The rapid-response, point-of-care tests should trim the long lines seen at some of the country's testing sites.

Zacks Investment Research - 2 weeks ago

Given the current testing requirements across the world, the diagnostic testing business for COVID-19 is rapidly evolving.

Other stocks mentioned: EXAS, HOLX, QGEN, TMO
The Motley Fool - 2 weeks ago

These three companies are stable, in demand, and capably led.

Other stocks mentioned: TMO, WBA
Zacks Investment Research - 2 weeks ago

Abbott (ABT) closed the most recent trading day at $108.56, moving +1.93% from the previous trading session.

Business Wire - 2 weeks ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into...

Other stocks mentioned: QTRX
Seeking Alpha - 2 weeks ago

ABT is securing more orders for millions of its rapid covid-19 testing kits.

The Motley Fool - 2 weeks ago

These two companies are making headway against the pandemic in key areas.

Other stocks mentioned: AZN
The Motley Fool - 2 weeks ago

With an increasing share of the coronavirus diagnostic testing market, Abbott is positioned for substantial growth.

The Motley Fool - 2 weeks ago

This new test is cheap, fast, reliable, and digitally integrated.

Latest From StockTwits